Stocks & ETFs Screener: 95 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
938B | 82.8% | 69.2% | 66.2% | 51.2 | 7.76% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
500B | 74.7% | 60.5% | 60.8% | 20.0 | 21.7% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
289B | 82.7% | 38.9% | 69.9% | 31.0 | 19.2% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
285B | 79.8% | 41.6% | 50.7% | 30.1 | 8.26% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
261B | 83.0% | 63.0% | 8.99% | 13.8 | -12.7% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
257B | 91.9% | 59.2% | 95.7% | 18.3 | 16.7% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
219B | 89.4% | 41.4% | -42.4% | 13.6 | -60.5% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
146B | 57.5% | 66.7% | -35.2% | 15.0 | -5.06% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
123B | 75.2% | 63.3% | -6.65% | 16.5 | -15.5% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
122B | 63.4% | 54.0% | 28.4% | 16.4 | -6.80% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
99.9B | 74.0% | 59.3% | -49.0% | 16.1 | -18.7% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
97.2B | 80.1% | 31.0% | 61.3% | 13.7 | 15.7% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
94.4B | 79.4% | 19.5% | 76.6% | 13.5 | 27.8% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
57.0B | 56.5% | 37.6% | -57.1% | 16.5 | -23.1% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
56.4B | 88.5% | 69.1% | -57.0% | 21.4 | -39.9% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
47.3B | 63.1% | 35.9% | 24.6% | 203 | -6.05% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
39.3B | 47.8% | 1.0% | 8.84% | - | 50.4% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic, CNS, Respiratory |
27.8B | 54.1% | 17.8% | 74.9% | 39.7 | 39.6% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Rare Disease, Cancer |
22.7B | 58.0% | 71.4% | 30.6% | 22.2 | 34.9% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
12.3B | 87.4% | 50.1% | 42.9% | 23.9 | -2.36% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
12.1B | 28.9% | 59.9% | -0.30% | - | -22.1% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.6B | 77.7% | 45.1% | 38.0% | 17.6 | -13.7% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.2B | 42.9% | - | 57.5% | 323 | 57.9% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.8B | 51.1% | - | 12.9% | - | 20.5% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
8.19B | 67.4% | - | 88.1% | 89.3 | 26.7% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
7.51B | 32.3% | - | 79.5% | - | 32.6% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.87B | 61.5% | - | 82.2% | - | 23.4% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.54B | 85.5% | 57.2% | 57.9% | 22.8 | -0.31% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.42B | 36.6% | - | 73.8% | - | 42.0% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
2.92B | 64.1% | 0.21% | -17.4% | 14.7 | -38.0% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
2.76B | 25.7% | - | 93.6% | - | 162% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.61B | 29.7% | - | 74.6% | - | 19.8% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.57B | 46.8% | - | 45.4% | - | 7.95% |
| TERN Terns |
Pharmaceuticals
TKI, THR-Agonist, GLP-1-Agonist |
2.48B | 33.8% | - | 66.6% | - | 299% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.27B | 52.3% | 4.23% | -31.6% | 6.30 | -25.4% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.11B | 75.5% | 49.4% | -25.3% | 16.9 | -6.71% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.10B | 63.6% | - | 79.3% | - | 87.5% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.05B | 91.9% | - | -25.8% | 11.2 | 3.96% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.84B | 56.8% | 50.9% | -86.4% | 3.70 | -58.9% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.79B | 70.3% | - | 93.1% | 49.8 | 27.7% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Precision Medicine, APOL1 |
1.74B | 24.1% | - | 92.0% | - | 128% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.74B | 48.3% | 73.3% | -78.4% | - | -56.3% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.70B | 61.2% | 34.5% | 83.5% | 25.1 | 51.7% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.69B | 37.5% | - | 92.3% | - | 353% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.9% | 2.39% | 62.3% | 13.4 | -4.18% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.61B | 30.2% | - | -3.57% | - | 150% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.48B | 80.1% | - | 80.9% | 28.8 | 40.2% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.48B | 26.3% | - | -80.3% | - | -46.6% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.44B | 44.5% | - | 78.8% | - | 6.87% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Treg Stimulator, PEG-CSF1, TNFR2 |
1.33B | 32.5% | - | 34.2% | - | 225% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.32B | 46.7% | - | 44.1% | - | -7.14% |
| RAPP Rapport |
Pharmaceuticals
Antiepileptic, Analgesic |
1.30B | 31.3% | - | 53.5% | - | 27.2% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
1.29B | 33.2% | - | 4.74% | - | -18.0% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.21B | 76.6% | - | -21.0% | 11.5 | -46.3% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.19B | 27.3% | - | 76.5% | - | 90.0% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
1.18B | 34.4% | - | 10.0% | - | -54.7% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.08B | 65.2% | - | 41.1% | - | 49.9% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.07B | 62.9% | - | 85.8% | - | 52.6% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.04B | 63.3% | - | -38.1% | 49.3 | 12.3% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Ampreloxetine |
1.01B | 51.2% | - | 67.0% | 35.0 | 64.8% |
| ARVN Arvinas |
Pharmaceuticals
PROTAC, Cancer, Breast, Prostate |
912M | 39.5% | - | -69.1% | - | -54.8% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
908M | 45.7% | - | -63.7% | - | -50.6% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
908M | 45.2% | - | 8.13% | 21.6 | 7.48% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
813M | 92.7% | - | 57.9% | 4.67 | -4.84% |
| AQST Aquestive |
Pharmaceuticals
Film-Based Drugs, Anaphylaxis |
750M | 59.4% | - | 75.9% | - | 29.1% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
713M | 33.8% | - | -12.0% | - | 204% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
629M | 40.7% | - | 23.9% | - | -14.6% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
490M | 22.9% | - | 49.5% | - | 103% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Liquor, Pre-Rolls |
448M | 50.9% | - | -28.9% | - | -21.8% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
444M | 28.9% | - | -39.6% | - | -52.8% |
| ETON Eton |
Pharmaceuticals
Hormone, Enzyme, Metabolic |
442M | 56.3% | - | 76.2% | - | 14.8% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Bipolar Depression, Major |
430M | 43.1% | - | -2.55% | - | 201% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
420M | 16.2% | - | -81.9% | - | -72.2% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox, TPOXX, Health |
418M | 79.6% | 89.2% | 27.0% | 5.67 | -10.3% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
382M | 44.5% | - | -64.1% | - | -79.9% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
319M | 30.5% | - | -49.3% | - | -32.3% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release, Formulation |
313M | 45.3% | - | 43.1% | - | 724% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
310M | 51.6% | - | -33.0% | 0.64 | -44.8% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
272M | 32.8% | - | -55.6% | - | -33.0% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Obesity |
260M | 25.5% | - | -11.3% | - | -16.5% |
| TVRD Tvardi |
Pharmaceuticals
Oral, STAT3, Inhibitor, Phase-2 |
242M | 28.2% | - | -68.6% | - | -62.3% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 27.8% | 1.0% | -34.5% | - | -51.9% |
| ACB Aurora Cannabis |
Pharmaceuticals
Dried Cannabis, Cannabis Oil |
238M | 66.2% | - | -36.1% | - | -7.78% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
232M | 35.4% | - | -29.6% | - | -5.43% |
| MDWD Mediwound |
Pharmaceuticals
Eschar,Burn,Therapy,Tissue,Biopharm.. |
230M | 19.8% | - | 32.1% | - | -14.5% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
223M | 24.4% | - | -23.7% | - | 26.6% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis,Flower,Pre-Rolls,Vapes,Edi.. |
210M | 39.7% | - | -27.3% | 157 | -0.53% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
162M | 45.7% | - | 17.6% | - | 45.4% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Disease |
144M | 39.9% | - | 0.42% | - | 74.1% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 33.9% | 0.17% | -45.0% | - | -8.88% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
125M | 67.5% | - | -45.0% | - | -22.7% |
| SLGL Sol Gel |
Pharmaceuticals
Acne Cream, Rosacea Cream |
99.1M | 26.0% | - | 14.6% | - | 594% |
| NTHI NeOnc Technologies |
Pharmaceuticals
NEO100, NEO212, Glioblastoma |
90.8M | 58.7% | - | -29.4% | - | -37.6% |
| CTXR Citius |
Pharmaceuticals
Immunotherapy, Antibiotic |
24.9M | 35.5% | - | -81.3% | - | -71.8% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual, Aspirin, Melatonin |
20.2M | 39.1% | - | -81.8% | - | -99.3% |